King Pharmaceuticals KG Loss and loss adjustment expense reserves
Loss and loss adjustment expense reserves at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's loss and loss adjustment expense reserves.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's loss and loss adjustment expense reserves?
- King Pharmaceuticals (KG) reported loss and loss adjustment expense reserves of -$16.74M in Q1 2026.